Ligand validation:6BYI

BMA: beta-D-mannopyranose

BMA is a Ligand Of Interest in 6BYI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BYI_BMA_A_901	38%	72%	0.174	0.874	0.47	0.58	-	-	0	0	100%	1
6BYI_BMA_B_902	24%	71%	0.221	0.85	0.5	0.6	-	-	1	0	100%	1
6BYI_BMA_B_901	23%	65%	0.194	0.815	0.53	0.8	-	-	0	0	100%	1
6BYI_BMA_A_902	8%	57%	0.273	0.74	0.65	0.97	-	2	0	0	100%	1
6BYI_BMA_A_903	7%	57%	0.243	0.689	0.69	0.96	-	1	0	0	100%	1
6BYG_BMA_A_901	83%	53%	0.089	0.946	1.08	0.75	-	-	1	0	100%	1
6BYE_BMA_A_902	24%	43%	0.148	0.774	1.3	0.96	1	-	0	0	100%	1
5IDB_BMA_A_1003	100%	57%	0.048	0.995	0.68	0.94	-	1	0	0	100%	1
2GUD_BMA_A_123	96%	59%	0.07	0.981	0.56	0.97	-	-	0	0	100%	0.25
5A7V_BMA_A_1385	95%	46%	0.07	0.976	0.76	1.34	1	3	0	0	100%	0.5
4CD4_BMA_A_1422	95%	68%	0.07	0.988	0.52	0.69	-	-	0	0	92%	0.9167
6Q4Y_BMA_A_401	93%	57%	0.071	0.967	0.46	1.17	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.